Epigenetic histone methylation modulates fibrotic gene expression

Journal of the American Society of Nephrology

Volumn 21, Issue 12, 2010, Pages 2069-2080

  Sun, Guangdong ^a,b   Reddy, Marpadga A ^a   Yuan, Hang ^a,b   Lanting, Linda ^a   Kato, Mitsuo ^a   Natarajan, Rama ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; HISTONE H3; HISTONE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE SET7; HISTONE METHYLTRANSFERASE SET9; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GLUCOSE INTAKE; KIDNEY FIBROSIS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; RAT;

EID: 78649879767     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010060633     Document Type: Article

References (52)

1. Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700, 2003 (Pubitemid 36724933)
2. Bottinger EP, Bitzer M: TGF-{beta} signaling in renal disease. J Am Soc Nephrol 13: 2600-2610, 2002
3. Reeves WB, Andreoli TE: Transforming growth factor beta contributes to progressive diabetic nephropathy. Proc Natl Acad Sci USA 97: 7667-7669, 2000
4. Ziyadeh FN, Sharma K: Overview: combating diabetic nephropathy. J Am Soc Nephrol 14: 1355-1357, 2003
5. Brosius FC III: New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy. Rev Endocr Metab Disord 9: 245-254, 2008
6. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93: 536-542, 1994
7. Ziyadeh FN, Han DC, Cohen JA, Guo J, Cohen MP: Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: Involvement of the transforming growth factor-beta system. Kidney Int 53: 631-638, 1998
8. Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91: 9436-9440, 1994
9. Wolf G, Ziyadeh FN: The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 29: 153-163, 1997 (Pubitemid 27020811)
10. Sakharova OV, Taal MW, Brenner BM: Pathogenesis of diabetic nephropathy: Focus on transforming growth factor-beta and connective tissue growth factor. Curr Opin Nephrol Hypertens 10: 727-738, 2001
11. Guha M, Xu ZG, Tung D, Lanting L, Natarajan R: Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. Faseb J 21: 3355-3368, 2007 (Pubitemid 47565554)
12. Baricos WH, Reed JC, Cortez SL: Extracellular matrix degradation by cultured mesangial cells: Mediators and modulators. Exp Biol Med (Maywood) 228: 1018-1022, 2003
13. Chen S, Carmen Iglesias-de la Cruz M, Jim B, Hong SW, Isono M, Ziyadeh FN: Reversibility of established diabetic glomerulopathy by anti-TGF-[beta] antibodies in db/db mice. Biochem Biophys Res Commun 300: 16-22, 2003
14. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97: 8015-8020, 2000
15. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996
16. Leehey DJ, Singh AK, Alavi N, Singh R: Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl 77: S93-S98, 2000
17. Hua X, Liu X, Ansari DO, Lodish HF: Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev 12: 3084-3095, 1998
18. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, Natarajan R: MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta- induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 104: 3432-3437, 2007
19. Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I, Rossi JJ, Natarajan R: TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11: 881-889, 2009
20. Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC: TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol, 284: F243-F252, 2003
21. Berger SL: Histone modifications in transcriptional regulation. Curr Opin Genet Dev 12: 142-148, 2002
22. Shilatifard A: Chromatin modifications by methylation and ubiquitination: Implications in the regulation of gene expression. Annu Rev Biochem 75: 243-269, 2006 (Pubitemid 44118033)
23. Jenuwein T, Allis CD: Translating the histone code. Science 293: 1074-1080, 2001
24. Martin C, Zhang Y: The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6: 838-849, 2005
25. Ruthenburg AJ, Allis CD, Wysocka J: Methylation of lysine 4 on histone H3: Intricacy of writing and reading a single epigenetic mark. Mol Cell 25: 15-30, 2007
26. Hampsey M, Reinberg D: Tails of intrigue: Phosphorylation of RNA polymerase II mediates histone methylation. Cell 113: 429-432, 2003
27. Shi Y, Whetstine JR: Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 25: 1-14, 2007
28. Li Y, Reddy MA, Miao F, Shanmugam N, Yee, J-K, Hawkins D, Ren B, Natarajan R: Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-{kappa}B-dependent inflammatory genes: Relevance to diabetes and inflammation. J Biol Chem 283: 26771-26781, 2008
29. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M: Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205: 2409-2417, 2008
30. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME, El-Osta A: Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58: 1229-1236, 2009
31. Chakrabarti SK, Francis J, Ziesmann SM, Garmey JC, Mirmira RG: Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells. J Biol Chem 278: 23617-23623, 2003
32. Ivanov GS, Ivanova T, Kurash J, Ivanov A, Chuikov S, Gizatullin F, Herrera-Medina EM, Rauscher F III, Reinberg D, Barlev NA: Methylation- acetylation interplay activates p53 in response to DNA damage. Mol Cell Biol 27: 6756-6769, 2007
33. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, Barlev NA, Reinberg D: Regulation of p53 activity through lysine methylation. Nature 432: 353-360, 2004
34. Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I: Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell 14: 175-182, 2004
35. Ea CK, Baltimore D: Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc Natl Acad Sci USA 106: 18972-18977, 2009
36. Yang XD, Huang B, Li M, Lamb A, Kelleher NL, Chen LF: Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. Embo J 28: 1055-1066, 2009
37. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T: Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116-120, 2001
38. El Gazzar M, Yoza BK, Chen X, Hu J, Hawkins GA, McCall CE: G9a and HP1 couple histone and DNA methylation to TNFalpha transcription silencing during endotoxin tolerance. J Biol Chem 283: 32198-32208, 2008
39. Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R: Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci USA 105: 9047-9052, 2008
40. Miao F, Wu X, Zhang L, Yuan YC, Riggs AD, Natarajan R: Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J Biol Chem 282: 13854-13863, 2007
41. Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P, Zhang Y: Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 8: 1207-1217, 2001
42. Nishioka K, Chuikov S, Sarma K, Erdjument-Bromage H, Allis CD, Tempst P, Reinberg D: Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev 16: 479-489, 2002
43. Berger SL: The complex language of chromatin regulation during transcription. Nature 447: 407-412, 2007 (Pubitemid 46816746)
44. Esteve PO, Chin HG, Benner J, Feehery GR, Samaranayake M, Horwitz GA, Jacobsen SE, Pradhan S: Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc Natl Acad Sci USA 106: 5076-5081, 2009
45. Inoue Y, Itoh Y, Abe K, Okamoto T, Daitoku H, Fukamizu A, Onozaki K, Hayashi H: Smad3 is acetylated by p300/CBP to regulate its transactivation activity. Oncogene 26: 500-508, 2007
46. Park SH, Lee SR, Kim BC, Cho EA, Patel SP, Kang HB, Sausville EA, Nakanishi O, Trepel JB, Lee BI, Kim SJ: Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells. J Biol Chem 277: 5168-5174, 2002
47. Noh H, Oh EY, Seo JY, Yu MR, Kim YO, Ha H, Lee HB: Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol 297: F729-F739, 2009
48. Yoshikawa M, Hishikawa K, Marumo T, Fujita T: Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. J Am Soc Nephrol 18: 58-65, 2007
49. Marumo T, Hishikawa K, Yoshikawa M, Hirahashi J, Kawachi S, Fujita, T: Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol 298: F133-F141, 2010
50. Pons D, de Vries FR, van den Elsen PJ, Heijmans BT, Quax PH, Jukema JW: Epigenetic histone acetylation modifiers in vascular remodelling: New targets for therapy in cardiovascular disease. Eur Heart J 30: 266-277, 2009
51. Xu ZG, Li SL, Lanting L, Kim YS, Shanmugam N, Reddy MA, Natarajan R: Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: Potential role in diabetic nephropathy. Kidney Int 69: 512-519, 2006
52. Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, Lanting L, Natarajan R: Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 281: 13685-13693, 2006